Literature DB >> 29348156

Development and feasibility of an eHealth tool for idiopathic pulmonary fibrosis.

Catharina C Moor1, Mirjam J G van Manen1, Nelleke C Tak1, Esther van Noort2, Marlies S Wijsenbeek3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29348156     DOI： 10.1183/13993003.02508-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  9 in total

1.  A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers.

Authors:  C C Moor; M Wapenaar; J R Miedema; J J M Geelhoed; P P Chandoesing; M S Wijsenbeek
Journal:  Respir Res       Date:  2018-05-29

2.  Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study.

Authors:  Marlies Wijsenbeek; Elisabeth Bendstrup; Claudia Valenzuela; Michael T Henry; Catharina Moor; Monica Bengus; Andras Perjesi; Frank Gilberg; Klaus-Uwe Kirchgaessler; Carlo Vancheri
Journal:  Adv Ther       Date:  2018-11-30       Impact factor: 3.845

3.  Patients' and healthcare professionals' perspectives on the idiopathic pulmonary fibrosis care journey: a qualitative study.

Authors:  Anouk Delameillieure; Fabienne Dobbels; Sarah Vandekerkhof; Wim A Wuyts
Journal:  BMC Pulm Med       Date:  2021-03-18       Impact factor: 3.317

4.  Care programs and their components for patients with idiopathic pulmonary fibrosis: a systematic review.

Authors:  Anouk Delameillieure; Sarah Vandekerkhof; Bastiaan Van Grootven; Wim A Wuyts; Fabienne Dobbels
Journal:  Respir Res       Date:  2021-08-16

5.  Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians.

Authors:  Malik Althobiani; Jaber S Alqahtani; John R Hurst; Anne-Marie Russell; Joanna Porter
Journal:  BMJ Open Respir Res       Date:  2021-12

Review 6.  Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review.

Authors:  Malik A Althobiani; Rebecca A Evans; Jaber S Alqahtani; Abdulelah M Aldhahir; Anne-Marie Russell; John R Hurst; Joanna C Porter
Journal:  ERJ Open Res       Date:  2021-12-20

7.  Home monitoring of lung function, symptoms and quality of life after admission with COVID-19 infection: The HOMECOMIN' study.

Authors:  Gizal Nakshbandi; Catharina C Moor; Esther J Nossent; J J Miranda Geelhoed; Sara J Baart; Bart G Boerrigter; Joachim G J V Aerts; Suzan F M Nijman; Helger Y Santema; Merel E Hellemons; Marlies S Wijsenbeek
Journal:  Respirology       Date:  2022-04-19       Impact factor: 6.175

8.  Use of the patientMpower App With Home-Based Spirometry to Monitor the Symptoms and Impact of Fibrotic Lung Conditions: Longitudinal Observational Study.

Authors:  Colin Edwards; Eamonn Costello; Nicola Cassidy; Bill Vick; Anne-Marie Russell
Journal:  JMIR Mhealth Uhealth       Date:  2020-11-20       Impact factor: 4.773

9.  The use of online visual analogue scales in idiopathic pulmonary fibrosis.

Authors:  Catharina C Moor; Remy L M Mostard; Jan C Grutters; Paul Bresser; Marlies S Wijsenbeek
Journal:  Eur Respir J       Date:  2022-01-13       Impact factor: 16.671
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.